Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 16, 2025 07:00 ET | Source: EDAP TMS S.A.

Focal One® HIFU Receives Prestigious Innovation Award

Focal One® HIFU Receives Prestigious Innovation Award AUSTIN, Texas, September 16, 2025 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, announced today...
September 09, 2025 09:05 ET | Source: Research and Markets

Urology Market Growth Analysis 2025-2030 - Minimally Invasive Procedures and Imaging Improvements Reshaping Workflow Efficiency and Patient Care Pathways

Dublin, Sept. 09, 2025 (GLOBE NEWSWIRE) -- The "Urology Market - Global Forecast 2025-2030" report has been added to ResearchAndMarkets.com's offering. The urology devices market is experiencing...
August 26, 2025 10:22 ET | Source: Trethera Corporation

Trethera Awarded $2.3 Million NIH Grant to Study TRE-515 Combined with Radiation Therapy in Prostate Cancer Preclinical Models

Fresh NIH funding follows FDA Fast Track designation, reinforcing confidence in TRE-515 potential to advance prostate cancer treatment.
July 14, 2025 04:17 ET | Source: Research and Markets

Prostate Care Market Report 2025-2031 | Medtronic, Johnson & Johnson, Boston Scientific, and Abbott Laboratories Dominate through Product Innovations, Clinical Trials, M&As, and Strategic Partnerships

Dublin, July 14, 2025 (GLOBE NEWSWIRE) -- The "Prostate Care Market (2025 Edition): Analysis By Treatment Type (Medications, Surgical Treatments, Minimally Invasive Therapies, and Radiation...
July 09, 2025 09:22 ET | Source: Trethera Corporation

FDA Grants Fast Track Designation for TRE-515 in Combination with Radiation Therapy for the Treatment of Metastatic Castration Resistant Prostate Cancer

TRE-515 receives FDA Fast Track for use with Pluvicto™ in advanced prostate cancer, aiming to improve outcomes in PSMA-positive, treatment-resistant cases.
July 08, 2025 06:00 ET | Source: Comphya SA

Comphya Closes Oversubscribed CHF 7.5 Million Series A Round to Advance U.S. and Australian Clinical Programs Following Strong Pilot Data

- IDE approval obtained; U.S. pilot study clinical site launched at Johns Hopkins- Series B round in planning to support pivotal U.S. trial- New CEO appointment signals next phase of growth and...
June 11, 2025 06:30 ET | Source: Teleflex Incorporated

Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men’s Health Month

Timed with National Men’s Health Month, the Prostate Monster ad campaign shines a light on quality-of-life issues associated with benign prostatic hyperplasia or BPH—a condition affecting millions of...
May 15, 2025 06:30 ET | Source: Teleflex Incorporated

Teleflex Showcases New Clinical Data Presented at the 2025 American Urological Association (AUA) Annual Meeting

Two Head-to-Head Randomized Trials Highlight Superior Early Patient Experience with the UroLift™ System for BPH1-2 First-Ever Analysis Utilizing the American Urological Association Quality Registry...
April 26, 2025 17:36 ET | Source: Zenflow

Three-Year Data of Zenflow’s Spring System Demonstrate Durability of Clinical Benefits for Patients Suffering from BPH

Zenflow, Inc. announced today the results of long-term data demonstrating that the investigational Zenflow Spring® System offers significant benefits.
April 16, 2025 14:38 ET | Source: Upsize LLC

UPDATE - Male Enhancement Procedure by Upsize LLC Surpasses 1,000 Cases, Drives Rapid National Expansion

Upsize LLC surpasses 1,000 non-surgical male enhancement procedures, grows to 20 physicians nationwide with proprietary dermal filler-based technique.